Ad is loading...
FHTX
Price
$8.01
Change
-$0.79 (-8.98%)
Updated
Nov 15 closing price
109 days until earnings call
GNLX
Price
$2.36
Change
-$0.58 (-19.73%)
Updated
Nov 15 closing price
Ad is loading...

FHTX vs GNLX

Header iconFHTX vs GNLX Comparison
Open Charts FHTX vs GNLXBanner chart's image
Foghorn Therapeutics
Price$8.01
Change-$0.79 (-8.98%)
Volume$240.96K
CapitalizationN/A
Genelux
Price$2.36
Change-$0.58 (-19.73%)
Volume$361.1K
CapitalizationN/A
FHTX vs GNLX Comparison Chart
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GNLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
FHTX vs. GNLX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Sell and GNLX is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (FHTX: $8.01 vs. GNLX: $2.36)
Brand notoriety: FHTX and GNLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 140% vs. GNLX: 227%
Market capitalization -- FHTX: $445.3M vs. GNLX: $81.5M
FHTX [@Biotechnology] is valued at $445.3M. GNLX’s [@Biotechnology] market capitalization is $81.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileGNLX’s FA Score has 0 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • GNLX’s FA Score: 0 green, 5 red.
According to our system of comparison, FHTX is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 4 TA indicator(s) are bullish while GNLX’s TA Score has 4 bullish TA indicator(s).

  • FHTX’s TA Score: 4 bullish, 5 bearish.
  • GNLX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both FHTX and GNLX are a bad buy in the short-term.

Price Growth

FHTX (@Biotechnology) experienced а -14.33% price change this week, while GNLX (@Biotechnology) price change was -19.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

FHTX is expected to report earnings on Mar 06, 2025.

GNLX is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($445M) has a higher market cap than GNLX($81.5M). FHTX YTD gains are higher at: 24.186 vs. GNLX (-83.155). GNLX has higher annual earnings (EBITDA): -25.61M vs. FHTX (-91.63M). FHTX has more cash in the bank: 285M vs. GNLX (33.6M). GNLX has less debt than FHTX: GNLX (2.21M) vs FHTX (40.9M). FHTX has higher revenues than GNLX: FHTX (35.2M) vs GNLX (8K).
FHTXGNLXFHTX / GNLX
Capitalization445M81.5M546%
EBITDA-91.63M-25.61M358%
Gain YTD24.186-83.155-29%
P/E RatioN/AN/A-
Revenue35.2M8K440,000%
Total Cash285M33.6M848%
Total Debt40.9M2.21M1,853%
TECHNICAL ANALYSIS
Technical Analysis
FHTXGNLX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 7 days ago
89%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GNLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSCAX27.980.22
+0.79%
Cove Street Capital Small Cap Val Instl
RLCAX9.75-0.03
-0.31%
Columbia Disciplined Value A
HIMDX28.73-0.13
-0.45%
Hennessy Cornerstone Mid Cap 30 Instl
TVLRX13.12-0.09
-0.68%
Touchstone Value R6
JEMSX30.80-0.24
-0.77%
JPMorgan Emerging Markets Equity I

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with NTLA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-8.98%
NTLA - FHTX
45%
Loosely correlated
-7.61%
RLAY - FHTX
43%
Loosely correlated
-8.84%
PRME - FHTX
40%
Loosely correlated
-6.95%
ABOS - FHTX
40%
Loosely correlated
-8.05%
CRSP - FHTX
40%
Loosely correlated
+0.85%
More

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-19.73%
VSTM - GNLX
48%
Loosely correlated
-3.39%
SNSE - GNLX
29%
Poorly correlated
-1.86%
FHTX - GNLX
29%
Poorly correlated
-8.98%
ROIV - GNLX
27%
Poorly correlated
-3.78%
ZLDAF - GNLX
26%
Poorly correlated
N/A
More